<li>alendronate<p>levothyroxine decreases levels of alendronate by unspecified interaction mechanism. Minor/Significance Unknown. Bioavailability of alendronate decreases slightly.</p></li><li>amobarbital<p>amobarbital decreases levels of levothyroxine by increasing metabolism. Minor/Significance Unknown.</p></li><li>butabarbital<p>butabarbital decreases levels of levothyroxine by increasing metabolism. Minor/Significance Unknown.</p></li><li>butalbital<p>butalbital decreases levels of levothyroxine by increasing metabolism. Minor/Significance Unknown.</p></li><li>carbamazepine<p>carbamazepine decreases levels of levothyroxine by increasing metabolism. Minor/Significance Unknown.</p></li><li>colestipol<p>colestipol decreases levels of levothyroxine by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.</p></li><li>dexlansoprazole<p>dexlansoprazole decreases levels of levothyroxine by increasing gastric pH. Applies only to oral form of both agents. Minor/Significance Unknown. Conflicting evidence regarding this interaction exists.</p></li><li>dyphylline<p>levothyroxine decreases levels of dyphylline by increasing elimination. Minor/Significance Unknown.</p></li><li>eptifibatide<p>levothyroxine decreases levels of eptifibatide by increasing renal clearance. Minor/Significance Unknown.</p></li><li>eslicarbazepine acetate<p>eslicarbazepine acetate decreases levels of levothyroxine by increasing metabolism. Minor/Significance Unknown.</p></li><li>esomeprazole<p>esomeprazole decreases levels of levothyroxine by increasing gastric pH. Applies only to oral form of both agents. Minor/Significance Unknown. Conflicting evidence regarding this interaction exists.</p></li><li>ethotoin<p>ethotoin decreases levels of levothyroxine by increasing metabolism. Minor/Significance Unknown.<span><br><br></span>ethotoin decreases levels of levothyroxine by plasma protein binding competition. Minor/Significance Unknown.</p></li><li>fosphenytoin<p>fosphenytoin decreases levels of levothyroxine by increasing metabolism. Minor/Significance Unknown.<span><br><br></span>fosphenytoin decreases levels of levothyroxine by plasma protein binding competition. Minor/Significance Unknown.</p></li><li>furosemide<p>furosemide increases toxicity of levothyroxine by Other (see comment). Minor/Significance Unknown. 
Comment: High doses (greater than 80 mg) of furosemide may inhibit binding of thyroid hormones to carrier proteins and result in transient increase in free thyroid hormones, followed by overall decrease in total thyroid hormone levels.</p></li><li>glandular products<p>glandular products increases effects of levothyroxine by pharmacodynamic synergism. Minor/Significance Unknown. Additive effects with thyroid glandular extract.</p></li><li>guggul<p>guggul decreases effects of levothyroxine by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>hexobarbital<p>hexobarbital decreases levels of levothyroxine by increasing metabolism. Minor/Significance Unknown.</p></li><li>lansoprazole<p>lansoprazole decreases levels of levothyroxine by increasing gastric pH. Applies only to oral form of both agents. Minor/Significance Unknown. Conflicting evidence regarding this interaction exists.</p></li><li>mephobarbital<p>mephobarbital decreases levels of levothyroxine by increasing metabolism. Minor/Significance Unknown.</p></li><li>omeprazole<p>omeprazole decreases levels of levothyroxine by increasing gastric pH. Applies only to oral form of both agents. Minor/Significance Unknown. Conflicting evidence regarding this interaction exists.</p></li><li>oxcarbazepine<p>oxcarbazepine decreases levels of levothyroxine by increasing metabolism. Minor/Significance Unknown.</p></li><li>pantoprazole<p>pantoprazole decreases levels of levothyroxine by increasing gastric pH. Applies only to oral form of both agents. Minor/Significance Unknown. Conflicting evidence regarding this interaction exists.</p></li><li>pentobarbital<p>pentobarbital decreases levels of levothyroxine by increasing metabolism. Minor/Significance Unknown.</p></li><li>phenobarbital<p>phenobarbital decreases levels of levothyroxine by increasing metabolism. Minor/Significance Unknown.</p></li><li>phenytoin<p>phenytoin decreases levels of levothyroxine by increasing metabolism. Minor/Significance Unknown.<span><br><br></span>phenytoin decreases levels of levothyroxine by plasma protein binding competition. Minor/Significance Unknown.</p></li><li>piracetam<p>piracetam, levothyroxine. Mechanism: unknown. Minor/Significance Unknown. Combination of piracetam and T3+T4 produced confusion, sleep disorder in single case.</p></li><li>primidone<p>primidone decreases levels of levothyroxine by increasing metabolism. Minor/Significance Unknown.</p></li><li>rabeprazole<p>rabeprazole decreases levels of levothyroxine by increasing gastric pH. Applies only to oral form of both agents. Minor/Significance Unknown. Conflicting evidence regarding this interaction exists.</p></li><li>rifampin<p>rifampin decreases levels of levothyroxine by increasing metabolism. Minor/Significance Unknown.</p></li><li>secobarbital<p>secobarbital decreases levels of levothyroxine by increasing metabolism. Minor/Significance Unknown.</p></li><li>shepherd's purse<p>shepherd's purse decreases effects of levothyroxine by unspecified interaction mechanism. Minor/Significance Unknown. Theoretical interaction.</p></li><li>sodium polystyrene sulfonate<p>sodium polystyrene sulfonate decreases levels of levothyroxine by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.</p></li><li>theophylline<p>levothyroxine decreases levels of theophylline by increasing elimination. Minor/Significance Unknown.</p></li><li>tirofiban<p>levothyroxine decreases levels of tirofiban by increasing renal clearance. Minor/Significance Unknown.</p></li>